Claritas HealthTech’s CystoSmart™: Revolutionary AI Diagnostic Tool for Bladder Cancer Detection Set to Transform Medical Diagnostics
London and New York, November 12, 2023 (GLOBE NEWSWIRE) – Claritas HealthTech announces a groundbreaking development in medical diagnostics with its subsidiary, Intelligent Scopes Corp (ISC), leading the worldwide delivery and deployment of CystoSmart™. This revolutionary AI diagnostic tool aims to transform the detection of bladder cancer through cutting-edge technology and image enhancement.
Bladder cancer is a prevalent form of cancer, ranking as the 10th most common cancer globally and the sixth most common in men. However, diagnostics using cystoscopes for bladder examination pose numerous challenges and require significant time and resources. CystoSmart™, developed through a research collaboration agreement with Khoo Teck Puat Hospital (KTPH) Singapore and with support from Singapore’s National Healthcare Group (NHG)’s Centre for Medical Technologies and Innovations (CMTi), presents an innovative solution to address these challenges.
CystoSmart™ utilizes image enhancement and artificial intelligence to achieve real-time precision detection of conditions in endoscopic and cystoscopic images, ensuring accurate identification of bladder cancer. The system is currently under review for clearance by the FDA, marking a significant step toward revolutionizing bladder cancer diagnostics.
Dr. Laszlo Neumann, Chief Technology Officer of Claritas, expresses excitement about the collaboration, stating, We are excited to be working with Singapore’s clinical team in developing CystoSmart™. Our joint objective has been to develop a precision AI tool that can be used as an aid by clinicians to significantly improve patient care.
Dr. Siying Yeow, clinical principal investigator for CystoSmart™ and a consultant urologist at KTPH, echoes this sentiment, emphasizing the tool’s potential to enhance the accuracy of bladder cancer detection. Our aim has been to develop an AI diagnostic tool that enhances the accuracy of detection of bladder cancers, says Dr. Yeow. CystoSmart™ will be beneficial in enabling appropriate treatment for newly diagnosed cancers, the accurate recognition of tumor recurrences, and complete tumor resection during surgery.
Claritas HealthTech, a leader in image enhancement and AI diagnostic solutions, focuses on research and development in medical image processing and AI-assisted interpretation and diagnostics. Compliant with HIPAA, PDPA, and GDPR requirements, Claritas aims to transform the diagnostics industry through powerful and effective software products created using their advanced technology.
Intelligent Scopes Corp, a subsidiary of Claritas, specializes in providing state-of-the-art image processing and enhancement software medical devices and AI diagnostic tools for urology and gastroenterology. Their strategic focus on research and development of image processing, image enhancement, AI diagnostic tools, and robotic guidance systems aims to improve detection rates, reduce unnecessary biopsies, and enhance patient outcomes.
Khoo Teck Puat Hospital (KTPH), a public hospital, is part of Singapore’s National Healthcare Group (NHG). With a focus on serving the northern sector of Singapore, KTPH provides general and acute care to more than 550,000 individuals. The collaboration with KTPH and the support from Singapore’s NHG’s Centre for Medical Technologies and Innovations (CMTi) have been instrumental in the development of CystoSmart™.
The deployment of CystoSmart™ is set to revolutionize bladder cancer diagnostics and improve patient outcomes worldwide. Through its AI-assisted detection capabilities and accurate recognition of bladder cancers, CystoSmart™ aims to enable timely treatment and enhance surgical procedures, ensuring an improved standard of care for individuals affected by this form of cancer.
For media inquiries or further information, please contact:
Claritas HealthTech: www.claritashealthtech.com
Intelligent Scopes Corp: www.intelligentscopes.com
Khoo Teck Puat Hospital (KTPH): https://www.ktph.com.sg/